![Zur Rose-Aktie verliert: Negative Kommentare zum deutschen E-Rezept belasten Zur Rose | 05.01.23 | finanzen.ch Zur Rose-Aktie verliert: Negative Kommentare zum deutschen E-Rezept belasten Zur Rose | 05.01.23 | finanzen.ch](https://images.finanzen.ch/images/unsortiert/zur-rose-by-org-2-660.jpg)
Zur Rose-Aktie verliert: Negative Kommentare zum deutschen E-Rezept belasten Zur Rose | 05.01.23 | finanzen.ch
![Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity](https://valueandopportunity.files.wordpress.com/2019/03/csm_zurrosegroupfinal_01_70165d445d.jpg?w=860)
Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
![Zur Rose's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile Zur Rose's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/logo/zur-rose-group_owler_20211209_110453_original.png)
Zur Rose's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
![Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity](https://valueandopportunity.files.wordpress.com/2019/03/zur-rose.png?w=640)